FDA 21 CFR Part 11 is the cornerstone regulation governing electronic records and electronic signatures in the pharmaceutical industry. Despite being in effect since 1997, it remains one of the most commonly cited regulations in FDA warning letters. This guide provides a clause-by-clause analysis of Part 11 requirements, maps them to specific ERP system controls, and provides practical implementation guidance with real-world examples from pharmaceutical ERP deployments.
Title 21, Code of Federal Regulations, Part 11 establishes the FDA's criteria for acceptance of electronic records and electronic signatures as equivalent to paper records and handwritten signatures. The regulation applies to all records required by FDA predicate rules (such as GMPs, GLPs, and device QSR) that are created, modified, maintained, archived, retrieved, or transmitted in electronic form.
A critical distinction that many organizations misunderstand is the difference between predicate rule requirements and Part 11 requirements. Predicate rules define what records must be kept and what they must contain. Part 11 defines the technical and procedural controls required when those records are maintained electronically. You cannot be compliant with Part 11 if you do not first understand which predicate rules apply to your operations.
The majority of pharmaceutical ERP systems qualify as closed systems — systems where access is controlled by the persons responsible for the content of electronic records. Section 11.10 establishes the baseline controls required for all closed systems maintaining electronic records.
The audit trail is arguably the most critical Part 11 control and the one most frequently found deficient during FDA inspections. A compliant audit trail must capture the complete history of every GxP-relevant record modification.
Enter your email to download the complete fda 21 cfr part 11 compliance guide: implementing electronic records and signatures in pharma erp with all frameworks, templates, and actionable insights.
A detailed technical guide for achieving FDA 21 CFR Part 11 compliance in pharmaceutical ERP systems. Covers closed system requirements, electronic signature controls, audit trail implementation, and validation documentation strategies.
No spam. Unsubscribe anytime.
Our team can help you put these insights into action. Get a personalized consultation.
Talk to an Expert